Gregg W. Stone, MD, FACC, FSCAI

Impact of Gender on the Incidence and Outcome of Contrast-Induced Nephropathy After Percutaneous Coronary Intervention

08/01/2008

Ioannis Iakovou , MD;

George D. Dangas , MD, PhD;

Gregg W. Stone , MD, FACC, FSCAI;

Roxana Mehran , MD;

Gary S. Mintz , MD;

Lowell F. Satler , MD;

Kenneth M. Kent , MD, PhD;

Augusto D. Pichard , MD, FACC, FSCAI;

Martin B. Leon , MD;

Martin Fahy , MSc;

Alexandra J. Lansky , MD;

Dale T. Ashby , MBBS, PhD;

Contrast-induced nephropathy (CIN) may occur after percutaneous coronary interventions (PCI), particularly in patients with baseline chronic renal failure (CRF) and diabetes mellitus.1–3 We have reported on the adverse impact of CIN post-PCI...

Contrast-induced nephropathy...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

The Association Between the Extent of Coronary Artery Disease and Major Bleeding Events After Percutaneous Coronary Intervention: From the ACUITY Trial

03/31/2015

Gregg W. Stone , MD, FACC, FSCAI;

Adriano Caixeta , MD, PhD;

Roxana Mehran , MD;

Mahesh V. Madhavan , MD;

Ajay J. Kirtane , MD, SM;

Ke Xu , PhD;

Thomas C. McAndrew , PhD, MS;

Tullio Palmerini , MD;

Dominic P. Francese , MPH;

The relationship between the extent of coronary artery disease (CAD) and bleeding after PCI remains understudied. This study sought to evaluate the relation between the extent of CAD and bleeding risk in patients undergoing PCI for non-ST...

The relationship between the...

03/31/2015

Journal of Invasive Cardiology

SPIRIT III: Comparison of the Xience V Everolimus-Eluting Coronary Stent System with the Taxus Paclitaxel-Eluting Coronary Stent

06/19/2008

Gregg W. Stone , MD, FACC, FSCAI;

The purpose of the Xience V stent was to try and put together a best-in-class drug, enhanced durable polymer and optimized metallic stent backbone. The drug that was used was everolimus, very similar to sirolimus, which is known to have very...

The purpose of the Xience V...

06/19/2008

Cath Lab Digest

Clinical Editor's Corner

Should We Do Elective Cardiac Catheterizations on the Weekends?

03/02/2022

Samuel M. Butman , MD;

Morton J. Kern , MD, MSCAI, FACC, FAHA;

Chet Rihal ;

Jeffrey W. Moses , MD;

Steven R. Bailey , MD;

Gurpreet S. Sandhu , MD, PhD;

Srihari S. Naidu , MD;

Frederick G.P. Welt , MD;

Kirk N. Garrett ;

Barry F. Uretsky , MD;

Lloyd W. Klein , MD;

Carl L. Tommaso , MD;

Gregg W. Stone , MD, FACC, FSCAI;

Richard Chazal , MD;

Duane S. Pinto , MD, MPH;

Rajiv Gulati , MD, PhD;

James C. Blankenship , MD;

David G. Rizik , MD, FACC, FSCAI;

Bonnie H. Weiner , MD, MBA, FSCAI, FACC;

The issue of working weekends to deliver more care is complex and requires a thoughtful game plan to commit the resources for the value of the expanded services. In the times of COVID, the need for hospital throughput has never been more...

The issue of working weekends to...

03/02/2022

Cath Lab Digest

Original Contribution

Mid-Term Results of Everolimus-Eluting Stent in a Japanese Population Compared With a US Randomized Cohort: SPIRIT III Japan Registry With Harmonization by Doing

08/29/2012

Alexandra J. Lansky , MD;

Krishnankutty Sudhir , MD, PhD;

Takaaki Isshiki , MD;

Tadashi Kikuchi , MD, PhD;

Hiroshi Nonogi , MD, PhD;

Keiichi Igarashi , MD;

Kenshi Fujii , MD;

Kumiko Saito , MS, MPH;

Hiroshi Fujita , MD;

Shigeru Nakamura , MD;

Shigeru Saito , MD;

Kazuaki Mitsudo , MD;

Masato Nakamura , MD;

Takeshi Kimura , MD;

Hauro Hirayama , MD, PhD;

Gregg W. Stone , MD, FACC, FSCAI;

Yasuhiro Honda , MD;

Peter J. Fitzgerald , MD, PhD;

Katsuhisa Waseda , MD, PhD;

Abstract: To address safety concerns with first-generation drug-eluting stents (DESs), the everolimus-eluting stent (EES) has been developed as a second-generation DES. The study aim was to: (1) demonstrate that use of the EES in Japanese...

Abstract: To address safety...

08/29/2012

Journal of Invasive Cardiology

Comparison of Safety and Efficacy Between First and Second Generation of Angio-Seal Closure Devices in Interventional Patients

08/01/2008

Emmanouil Tsounias , MD;

Paras C. Udani , DO;

Milena Adamian , MD;

Julia Adamian , MD;

Issam Moussa , MD;

Gregg W. Stone , MD, FACC, FSCAI;

Gary S. Mintz , MD;

George D. Dangas , MD, PhD;

Roxana Mehran , MD;

Jeffrey W. Moses , MD;

Michael B. Collins , MD;

Zoran Lasic , MD;

Eugenia Nikolsky , MD, PhD;

There are two principal approaches to achieve femoral artery hemostasis following diagnostic cardiac catheterization or percutaneous coronary intervention (PCI): manual compression or arterial closure devices.1–6 Arterial closure devices are...

There are two principal...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Serial Intravascular Ultrasound Analysis of Stent Strut Distribution and Fracture: An Integrated Analysis of the Taxus IV, V, and VI Trials

09/27/2014

Stephen G. Ellis , MD;

Jeffrey J. Popma , MD, FACC, FSCAI;

Radoslaw Pracon , MD;

Jerzy Pregowski , MD, PhD;

Maksymilian P. Opolski , PhD, MD;

Mariusz Kruk , MD;

Lazar Mandinov , MD;

Hong Wang ;

Gregg W. Stone , MD, FACC, FSCAI;

Gary S. Mintz , MD;

Neil J. Weissman , MD;

Keith D. Dawkins , MD, FRCP, FACC;

Eberhard Grube , MD;

Non-uniform distribution of drug-eluting stent struts may cause uneven drug deposition associated with an adverse neointimal response and clinical events. This study assesses circumferential stent strut distribution in bare-metal (BMS, n=117)...

Non-uniform distribution of...

09/27/2014

Journal of Invasive Cardiology

Feature

The ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) Trial: What`s the Next Step for Bivalirudin After R

06/19/2008

Gregg W. Stone , MD, FACC, FSCAI;

What is the basic study strategy behind the ACUITY trial? ACUITY will enroll 13,800 patients with moderate-to-high unstable angina, all of whom are intended to undergo an invasive strategy. These patients will usually be in the cath lab...

What is the basic study strategy...

06/19/2008

Cath Lab Digest

Abdalwahab Myocardial Muscle Bridges Figure 1

Brief Communication

Percutaneous Coronary Intervention and Stenting for the Treatment of Myocardial Muscle Bridges: A Consecutive Case Series

04/01/2023

Mohamed Farag , MSc, PhD;

Tarik Salim , MD;

Mohaned Egred , MBChB, MD, BSc(Hons), FRCP, BSc, MRCP;

Gregg W. Stone , MD, FACC, FSCAI;

Ahmed Abdalwahab , MSc;

Mina S.A. Ghobrial , MBBS, MRCP, BMedSci, MBChB;

The authors analyzed data on patients with symptomatic myocardial muscle bridge to describe the experience and outcomes of percutaneous coronary intervention and stent insertion as treatment.

The authors analyzed data on...

04/01/2023

Journal of Invasive Cardiology

Original Contribution

Gender Differences in Long-Term Clinical Outcomes After Percutaneous Coronary Intervention of Chronic Total Occlusions

10/01/2012

George D. Dangas , MD, PhD;

Jose P.S. Henriques , MD, PhD;

Roxana Mehran , MD;

Alaide Chieffo , MD;

Jeffrey W. Moses , MD;

Seung-Whan Lee , MD, PhD;

Seung-Jung Park , MD, PhD;

Mauro Carlino , MD;

Gregg W. Stone , MD, FACC, FSCAI;

Martin B. Leon , MD;

Bimmer E. Classen , MD, PhD;

Carlo Di Mario , MD, PhD, FESC, FACC, FRCP;

Cosmo Godino , MD;

Antonio Colombo , MD;

Kotaro Obunai , MD;

Vaso Chantziara , MD;

Irini Apostolidou , MD;

Abstract: Introduction. Little is known about gender differences among patients undergoing percutaneous coronary intervention (PCI) for chronic total occlusion (CTO). Methods. A total of 1791 patients with 1852 CTOs underwent PCI at 3 centers...

Abstract: Introduction. Little...

10/01/2012

Journal of Invasive Cardiology